Article: Publication No. WO/2009/117769 Published on Oct. 1, Assigned to NEWCASTLE INNOVATION for Cancer Inhibition (Australian Inventors)

GENEVA, Oct. 5 -- Nicole Margaret Verrills and Kathryn Grace Roberts, both of Australia, have developed an inhibition of c-kit cancers.

The patent has been assigned to NEWCASTLE INNOVATION LTD., New South Wales, Australia.

According to an abstract posted by the World Intellectual Property Organization, the invention relates to a "method for inhibiting c-KIT in a cancer cell, comprising treating the cancer cell with an agent for up regulating protein phosphatase 2A activity in the cancer cell. The agent can be an activator of protein phosphatase 2A such as fingolimod. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!